Department of Reproduction and Genetics, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Thyroid. 2022 Jun;32(6):705-713. doi: 10.1089/thy.2022.0049. Epub 2022 May 24.
A recent study showed that paternal subclinical hypothyroidism adversely affects the clinical outcomes of assisted reproductive technologies (ARTs). The aim of this study was to determine whether paternal serum-free thyroxine (fT4) concentrations within the reference range are associated with ART outcomes. This retrospective cohort study included 4066 couples who received 4894 ART treatment cycles in our clinic between April 1, 2016 and August 31, 2021. The differences in sperm parameters and ART outcomes across the paternal fT4 concentration tertiles were compared by using generalized linear models or generalized estimation equation models. The primary outcomes were clinical pregnancy rate (CPR) and live birth rate (LBR) per oocyte retrieval after the first embryo transfer cycle. The mean ages of the males and their female partners were 32.8 (standard deviation, 5.0) and 30.7 (standard deviation, 4.1) years, respectively. No significant differences were observed in the sperm parameters or ART outcomes between the paternal fT4 concentration tertiles of the overall population. However, a stratified analysis of men aged ≥35 showed an adjusted CPR of 0.36 [confidence interval, CI: 0.27-0.45] for the lower paternal fT4 concentration tertile relative to the middle (adjusted rate: 0.45, CI: 0.38-0.53) and upper (adjusted rate: 0.43, CI: 0.36-0.51) tertiles ( for trend >0.05). The adjusted LBRs were 0.21 [CI: 0.15-0.30] for men aged ≥35 in the lower fT4 concentration tertile ( = 0.024, with reference to the upper tertile), 0.27 [CI: 0.21-0.35] for those in the middle tertile, and 0.30 [CI: 0.23-0.38] for those in the upper tertile. No differences in these outcomes were observed in men aged <35. The nonlinear smoothing curve obtained by using fT4 concentration as a continuous variable further supported these findings. Men of older reproductive age (≥35 years old) with low-normal fT4 concentrations within the reference range are associated with a decreased LBR. Future prospective studies are warranted to confirm the detrimental effects of low-normal paternal fT4 concentrations on ART outcomes.
最近的一项研究表明,父系亚临床甲状腺功能减退症会对辅助生殖技术(ART)的临床结局产生不利影响。本研究旨在确定父系血清游离甲状腺素(fT4)浓度在参考范围内是否与 ART 结局相关。本回顾性队列研究纳入了 2016 年 4 月 1 日至 2021 年 8 月 31 日期间在我院接受 4894 个 ART 治疗周期的 4066 对夫妇。使用广义线性模型或广义估计方程模型比较了父系 fT4 浓度三分位组之间的精子参数和 ART 结局差异。主要结局是首次胚胎移植周期后每个卵母细胞回收的临床妊娠率(CPR)和活产率(LBR)。男性和女性伴侣的平均年龄分别为 32.8(标准差 5.0)和 30.7(标准差 4.1)岁。在整个人群中,父系 fT4 浓度三分位组之间的精子参数或 ART 结局没有差异。然而,对年龄≥35 岁的男性进行分层分析显示,与中(校正率:0.45,CI:0.38-0.53)和上(校正率:0.43,CI:0.36-0.51)三分位组相比,下(校正率:0.36,CI:0.27-0.45)fT4 浓度三分位组的校正 CPR 为 0.36 [95%置信区间(CI):0.27-0.45](趋势检验>0.05)。年龄≥35 岁的男性中,下 fT4 浓度三分位组的校正 LBR 为 0.21 [95%CI:0.15-0.30](与上三分位组相比, =0.024),中三分位组为 0.27 [95%CI:0.21-0.35],上三分位组为 0.30 [95%CI:0.23-0.38]。年龄<35 岁的男性未观察到这些结局的差异。使用 fT4 浓度作为连续变量获得的非线性平滑曲线进一步支持了这些发现。处于生育晚期(≥35 岁)的男性,其参考范围内的正常低 fT4 浓度与较低的 LBR 相关。需要进一步的前瞻性研究来证实正常低值父系 fT4 浓度对 ART 结局的不良影响。